Regeneron expects 2027 R&D expense to rise by a mid-teens percentage while recording a $1B Sanofi upfront payment in Q4

Seeking Alpha · 市场快讯 · October 30, 2026 at 2:40 PM ET

Read the full report at the original publisher.